RBF Capital’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
Other funds holding STIM
MCM
FCM
GCP
RBF Capital's STIM Position: Q4 2024 in Review
RBF Capital sold out of Neuronetics (STIM) in Q4 2024, closing a stake of 58,753 shares — an estimated $44.6K sold.
RBF Capital first reported a position in STIM in Q4 2021 and held it in 12 quarters. The position peaked at $558K in Q4 2021. 45 funds tracked by Wall St. Rank hold STIM as of Q4 2024.
- RBF Capital reported no remaining Neuronetics position as of Q4 2024 after selling out during the quarter.
- RBF Capital sold 58,753 Neuronetics shares in Q4 2024, an estimated $44.6K.
- RBF Capital first reported a position in Neuronetics in Q4 2021 and held it in 12 quarters.
- RBF Capital's Neuronetics position peaked at $558K in Q4 2021.
- 45 funds tracked by Wall St. Rank held Neuronetics as of Q4 2024.
Based on RBF Capital's 13F filing for Q4 2024, filed 14 Feb 2025.